Skip to main content
. 2017 May 22;8(46):80336–80347. doi: 10.18632/oncotarget.18165

Table 3. Prognostic value of risk score stratified by histological type and treatment modality.

Parameters Number HR 95% CIs P
Histological type
Leiomyosarcoma (LMS) 103 2.901 1.538 5.473 0.001
Dedifferentiated liposarcoma 58 3.952 1.529 10.211 0.005
Undifferentiated pleomorphic sarcoma 51 2.116 0.679 6.596 0.196
Treatment modality
Radiation therapy 178 3.865 2.267 6.588 < 0.001
Non-radiation therapy 73 3.082 1.298 7.318 0.011